Virginia Commonwealth University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).

558 total trials 77 currently recruiting 380 completed early-phase tilt top decile by trial count

Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.

Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

558 total, page 3 of 12

COMPLETED Phase 1

Impact of Competency-Based Training and Technical Assistance Employment Outcomes of Individuals With ID/DD

NCT06586827

COMPLETED NA

Improving Access to Community-Based Occupations Via a Rideshare Training Program

NCT06323850

COMPLETED NA

Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD

NCT06190236

COMPLETED Phase 1

Impact VR: An Emotion Recognition and Regulation Training Program for Youth With CD

NCT06301516

COMPLETED NA

Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca

NCT06250751

COMPLETED

Translational Research Center in Lung Cancer Disparities (TRACER) Project 2

NCT05490251

COMPLETED NA

Redesigning Pediatric Primary Care Obesity Treatment: Virtual House Calls

NCT06078774

COMPLETED NA

Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

NCT06043531

COMPLETED NA

Feasibility Study: Educational Genetic Test Video

NCT06166758

COMPLETED NA

WE Project: 2.0 Grassroots Wellness Coaching (Phase 2)

NCT06172582

COMPLETED NA

CALM: Managing Distress in Malignant Brain Cancer

NCT06180460

COMPLETED NA

Healthy Hydration Pilot in Elementary Schools

NCT06132763

TERMINATED NA

Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation

NCT05987813

COMPLETED NA

Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium

NCT06161480

COMPLETED

Exploring Virtual Reality in Clinical Care - Impacts on Patient Distress, Parental Anxiety and Nurse Satisfaction

NCT07280910

COMPLETED NA

The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

NCT05924919

COMPLETED Phase 1

Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion

NCT05976646

COMPLETED

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

NCT05984667

COMPLETED NA

Chronobiology of Meal Timing: Effects on Vascular and Renal Function

NCT05987566

COMPLETED NA

Engaging Black Men in Colorectal Cancer Screening

NCT05980182

COMPLETED NA

Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)

NCT05971823

COMPLETED NA

Determination of Liquid Flavor and Nicotine Form Outcomes

NCT05587504

COMPLETED NA

Genetic and Neural Factors in Alcohol-Related Cognition

NCT03725345

COMPLETED NA

The Role of Therapy Dogs in Reducing Depression, Anxiety, and Loneliness Among Hospitalized Children

NCT05551156

COMPLETED NA

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health

NCT05814575

COMPLETED NA

Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management

NCT05544708

TERMINATED NA

Antiretroviral Improvement Among Medicaid Enrollees

NCT05477485

COMPLETED

Lived Experiences of Black Girls in Richmond

NCT05858281

COMPLETED NA

The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment

NCT04522973

COMPLETED NA

Effects of Smartphone-Based Stress Reduction Training on Social Relations

NCT05730270

COMPLETED NA

Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

NCT05728866

COMPLETED NA

Fasting Versus Non-fasting on Outcomes and Satisfaction Prior to Cardiac Catheterization

NCT05851872

TERMINATED Early Phase 1

Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)

NCT05605548

COMPLETED NA

Effects and Mechanisms of Smartphone-Based Stress Management Training on Well-Being in College Students

NCT05518656

COMPLETED NA

Effect of Parenting With Positive Interven on Comm Inclusion for Military Connected and Dependents With Autism

NCT05580432

COMPLETED Early Phase 1

A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies

NCT05557812

COMPLETED Phase 1

Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

NCT06077214

COMPLETED

Immune Registry for Organ Transplantation From COVID Positive Donors.

NCT05595837

COMPLETED NA

Determination of Core Body Temperature in Parturient Warmed With Upper or Underbody Forced Air Cover (Bair Hugger)

NCT05314075

COMPLETED NA

The Abuse Liability of a Novel Heated Tobacco Product (IQOS) and Its Feasibility as a Menthol Cigarette Substitute

NCT05499377

COMPLETED NA

FearLess in Cognitively Intact Patients With Glioma

NCT05604365

TERMINATED NA

Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers

NCT05590273

COMPLETED NA

Effects of an Oral Nicotine Product in Smokeless Tobacco Users

NCT05280769

COMPLETED NA

Use of Stable Airway Management Device in Monitored Anesthesia Care

NCT05087979

TERMINATED NA

Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women

NCT04275310

COMPLETED Phase 2

Istradefylline for Parkinson Disease With Cognitive Impairment

NCT05333549

COMPLETED NA

A Strategy to Prevent the Recurrence of Dental Disease in Children Receiving Dental Treatment With General Anesthesia

NCT05212142

COMPLETED NA

Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1

NCT05377008

COMPLETED NA

Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers

NCT05023096

COMPLETED NA

Art for Hearts/Black Women's Hearts Paint Night

NCT05252507

← Previous Page 3 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 65
Phase 3 13
Phase 4 22

What is open in the Virginia Commonwealth University pipeline

77 recruiting of 558 indexed (14% open); 380 completed (68%).

Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Virginia Commonwealth University: open-pipeline peers nationwide

Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Virginia Commonwealth UniversityAmgenMerck Sharp & DohmeUniversity of Maryland, BaltimoreOhio State UniversityLindenwood UniversityBeiGeneReproductive Medicine Associates of New JerseyUniversity of Cincinnati
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 558 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Virginia Commonwealth University page

558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.

  • 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.